Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aduro Biotech (ADRO)

6.6 0.4 (6.45%)

02-23 16:00

Open:

6.2

Pre. Close:

6.2

High:

6.7

Low:

6.125

Volume:

553,962

Market Cap:

510M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.709 - 6.736

6.736 - 6.762

Low:

6.067 - 6.095

6.095 - 6.122

Close:

6.552 - 6.599

6.599 - 6.644

Technical analysis  (as of: 2018-02-23 4:39:53 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 8.18     One year: 9.02

Support:

Support1: 5.82    Support2: 4.85

Resistance:

Resistance1: 7.00    Resistance2: 7.72

Pivot:

6.18

Moving Averages:

MA(5): 6.21     MA(20): 6.28

MA(100): 8.00     MA(250): 9.77

MACD:

MACD(12,26): -0.24     Signal(12,26,9): -0.32

%K %D:

%K(14,3): 46.80     %D(3): 33.17

RSI:

RSI(14): 51.82

52-Week:

High: 14.05  Low: 5.825  Change(%): -43.1

Average Vol(K):

3-Month: 52547  10-Days 47212

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ADRO has closed It is unclear right now based on current numbers. 65.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADRO's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 16 Oct 2017 11:45:48 GMT
Cantor Fitzgerald Begins Coverage on Aduro BioTech (ADRO)

Tue, 12 Sep 2017 11:44:31 GMT
Head-To-Head Review: Aduro BioTech (ADRO) versus Tocagen (TOCA)

Fri, 23 Feb 2018 22:30:00 GMT
Aduro Biotech Inc. (ADRO) Soars 6.45% on February 23

Fri, 05 Jan 2018 12:56:15 GMT
Aduro Biotech Announces Management Changes

Tue, 12 Dec 2017 13:03:51 GMT
Aduro Biotech Provides Update on CRS-207 Programs

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

77.30

Shares Float (M)

76.10

% Held by Insiders

% Held by Institutions

66.10

Shares Short (K)

6588

Shares Short Prior Month (K)

5810

Stock Financials

EPS

-1.360

EPS Est. Current Year

-1.350

EPS Est. Next Year

-1.270

EPS Est. Next Quarter

-0.380

Forward EPS

-1.330

Book Value (p.s.)

1.820

PEG Ratio

4.30

Profit Margin

Operating Margin

-596.26

Return on Assets (ttm)

-20.0

Return on Equity (ttm)

-36.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.289

Qtrly Earnings Growth

Operating Cash Flow (M)

-90.09

Levered Free Cash Flow (M)

-62.40

atoplab.com

Valuation

P/E

-4.85

P/E Growth Ratio

0.06

P/BV

3.63

P/S

2040719872.00

P/CF

-5.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.